Geoepidemiological analysis of covid-19 cases in pregnant women: a descriptive study
DOI:
https://doi.org/10.21527/2176-7114.2026.51.16604Keywords:
Pregnant women, COVID-19, Spatial analysisAbstract
Objectives: To describe the clinical-epidemiological aspects and spatial distribution of COVID-19 in pregnant women in a municipality in the state of Maranhão, Brazil. Methods: A descriptive and ecological study with a quantitative approach, based on cases notified to the Notifiable Diseases Information System (SINAN) between May 2020 and October 2021. The variables used were: age, skin color/ethnicity, healthcare professional status, municipality of residence, street, neighborhood, signs and symptoms, comorbidities, tests performed, test completion, and case outcomes. Data were tabulated, followed by descriptive analysis, incidence calculation, and geoepidemiological analysis. The study was approved by the Research Ethics Committee of the Federal University of Maranhão under opinion No. 4,754,078. Results: 313 pregnant women were analyzed. The incidence was 64.40/1000 inhabitants. The age group most represented was 26 to 35 years, most pregnant women identified as mixed-race, and 8 were healthcare professionals. Symptoms such as fever, cough, sore throat, and dyspnea were prominent. The most frequent health conditions were diabetes and decompensated chronic respiratory diseases. Five census tracts with a significant occurrence of COVID-19 in pregnant women were identified in the municipality. Conclusions: The group most affected by COVID-19 consisted of young adult women, mixed-race, and from census tracts with low socioeconomic status. The research provides data that can assist managers in formulating prevention and assistance strategies for future health crises.
References
1. World Health Organization. WHO Coronavirus (COVID-19) dashboard [Internet]. Geneva: WHO; [cited 2023 Jul 5]. Available from: https://covid19.who.int
2. Brasil. Ministério da Saúde. Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil [Internet]. Brasília: Ministério da Saúde; 2024 [cited 2023 Sep 12]. Available from: https://covid.saude.gov.br
3. Brasil. Ministério da Saúde. Observatório Obstétrico Brasileiro [Internet]. Brasília: Ministério da Saúde; 2024 [cited 2023 Sep 13]. Available from: https://observatorioobstetrico.shinyapps.io/covid_gesta_puerp_br
4. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica: emergência de saúde pública de importância nacional pela doença pelo coronavírus 2019 – COVID-19. Brasília: Ministério da Saúde; 2022.
5. Parenti ABH, Cruz CS, Berzuini GA, Bernardo LS, Silva TGM, Clapis MJ, et al. Saúde da gestante no contexto de emergência em saúde pública: reflexos da pandemia da COVID-19. Res Soc Dev. 2022;11(4):e59811427647. doi:10.33448/rsd-v11i4.27647.
6. Abou Ghayda R, Li H, Lee KH, Lee HW, Hong SH, Kwak M, et al. COVID-19 and adverse pregnancy outcome: a systematic review of 104 cases. J Clin Med. 2020;9(11):3441. doi:10.3390/jcm9113441.
7. Barcelos IDES, Penna IA, Soligo AG, Costa ZB, Martins WP. Vertical transmission of SARS-CoV-2: a systematic review. Rev Bras Ginecol Obstet. 2021;43(3):207–215. doi:10.1055/s-0040-1722256.
8. Sutton D, Bertozzi-Villa C, Lasky J, Fuchs K, Friedman A. Outcomes and epidemiology of COVID-19 infection in the obstetric population. Semin Perinatol. 2020;44(7):151283. doi:10.1016/j.semperi.2020.151283.
9. Junaid Sheikh, Lawson H, Allotey J, Yap M, Balaji R, Kew T, Stallings E, Coomar D, Gaetano-Gil A, Zamora J, Thangaratinam S; PregCOV-19 Living Systematic Review Consortium. Global variations in the burden of SARS-CoV-2 infection and its outcomes in pregnant women by geographical region and country's income status: a meta-analysis. BMJ Global Health. 2022 Nov;7(11):e010060. doi:10.1136/bmjgh-2022-010060. PMID:36368768; PMCID:PMC9659713.
10. Nogueira CMC, Alcantara JR, Costa HMG, Morais FRR, Bezerra KP, Fialho AVM. National analysis of the profile of pregnant women affected by COVID-19. Braz J Health Rev. 2020;3(5):14267–14278. doi:10.34119/bjhrv3n5-228.
11. Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y, et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(7):e901–e908. doi:10.1016/S2214-109X(20)30229-1.
12. Peres GP, Ferraz JG, Matos AFM, Zöllner MSA. Perfil epidemiológico das gestantes infectadas pela COVID-19. Braz J Infect Dis. 2022;26:102587. doi:10.1016/j.bjid.2022.102587.
13. Francisco RPV, Lacerda L, Rodrigues AS. Obstetric Observatory BRAZIL – COVID-19: 1031 maternal deaths because of COVID-19 and the unequal access to health care services. Clinics (Sao Paulo). 2021;76:e3120. doi:10.6061/clinics/2021/e3120.
14. Ferreira RBS, Camargo CL, Sousa AR, Whitaker MCO. Morbidity and mortality of pregnant women due to COVID-19 and racial biases: an intersectional analysis. Online Braz J Nurs. 2022;21(suppl 2):e20226553. doi:10.17665/1676-4285.2022.6553.
15. Sousa IMO. Representações sociais de gestantes sobre a realização do pré-natal na pandemia da COVID-19 [dissertation]. São Luís: Universidade Federal do Maranhão; 2023.
16. Rocha APN, Almeida JS, Miranda MRC. Perfil epidemiológico da mortalidade materna no estado do Maranhão, 2011 a 2020. Int J Dev Res. 2022;12(10):59475–59479. doi:10.37118/ijdr.25438.10.2022.
17. Alves de Oliveira R, Santos Neto M, Pascoal LM, Bezerra JM, Santos FS, Brito PS, et al. Severe acute respiratory syndrome by COVID-19: clinical-epidemiological profile and spatial distribution of deaths in Brazilian federative units. Mundo Saude. 2022;46:620–635. doi:10.15343/0104-7809.202246620635p.
18. Ibiapina É, Bernardes A. O mapa da saúde e o regime de visibilidade contemporâneo. Saude Soc. 2019;28(1):322–336. doi:10.1590/S0104-12902019170982.
19. Brasil. Ministério da Saúde. Portaria nº 1.631/GM, de 1º de outubro de 2015. Aprova critérios e parâmetros para o planejamento e programação de ações e serviços de saúde no âmbito do SUS. Brasília: Ministério da Saúde; 2015
20. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The STROBE Statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.
21. Instituto Brasileiro de Geografia e Estatística. Censo Demográfico 2010: resultados do universo por setor censitário [Internet]. Rio de Janeiro: IBGE; 2010 [cited 2023 Jul 5]. Available from: https://censo2010.ibge.gov.br
22. Takemoto MLS, Menezes MO, Andreucci CB, Nakamura-Pereira M, Amorim MMR, Katz L, et al. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int J Gynaecol Obstet. 2020;151(1):154–156. doi:10.1002/ijgo.13300.
23. Wang Z, Wang Z, Xiong G. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China. Int J Gynaecol Obstet. 2020;150(3):312–317. doi:10.1002/ijgo.13265.
24. Godoi APN, Bernardes GCS, Almeida NA, Melo SN, Belo VS, Nogueira LS, et al. Severe acute respiratory syndrome by COVID-19 in pregnant and postpartum women. Rev Bras Saude Mater Infant. 2021;21(Suppl 2):461–469. doi:10.1590/1806-9304202100S200008
25. Brasil. Conselho Nacional de Saúde. Recomendação nº 004, de 30 de março de 2021. Brasília: CNS; 2021.
26. Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian SE, et al. Maternal death due to COVID-19. Am J Obstet Gynecol. 2020;223(1):109.e1–109.e16. doi:10.1016/j.ajog.2020.04.030.
27. Oppenheimer D, Fernandes MT, Mesquita NL. COVID-19 e gestação: principais manifestações clínicas e laboratoriais e possíveis complicações. Res Soc Dev. 2022;11(12):e279111234427. doi:10.33448/rsd-v11i12.34427.
28. Huntley BJF, Huntley ES, Di Mascio D, Chen T, Berghella V, Chauhan SP. Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by SARS-CoV-2 infection: a systematic review. Obstet Gynecol. 2020;136(2):303–312. doi:10.1097/AOG.0000000000004010.
29. Lopes de Sousa ÁF, Carvalho HEF, Oliveira LB, Schneider G, Camargo ELS, Watanabe E, et al. Effects of COVID-19 infection during pregnancy and neonatal prognosis: what is the evidence? Int J Environ Res Public Health. 2020;17(11):4176. doi:10.3390/ijerph17114176.
30. Magno L, Rossi TA, Mendonça-Lima FW, Santos CC, Campos GB, Marques LM, et al. Desafios e propostas para ampliação da testagem e diagnóstico para COVID-19 no Brasil. Cien Saude Colet. 2020;25(9):3355–3364. doi:10.1590/1413-81232020259.17812020.
31. Brasil. Ministério da Saúde. Nota Técnica nº 14/2022-CGGRIPE/DEIDT/SVS/MS [Internet]. Brasília: Ministério da Saúde; 2022 [cited 2023 Jul 5]. Available from: https://www.gov.br/saude
32. Takemoto MLS, Menezes MO, Andreucci CB, Nakamura-Pereira M, Amorim MMR, Katz L, Knobel R. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. International Journal of Gynecology & Obstetrics. 2020 Oct;151(1):154-156. doi:10.1002/ijgo.13300.
33. Barja-Ore J, Valverde-Espinoza N, Campomanes-Pelaez E, Alaya Rodríguez N, Sánchez Garavito E, Silva Ramos J, et al. Características epidemiológicas y complicaciones obstétricas en gestantes con diagnóstico de COVID-19 en un hospital público. Rev. cuba. med. mil [Internet]. 15 de noviembre de 2021 [citado 9 de marzo de 2026];50(4):e02101644. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1644
34. Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian SE, et al. Maternal death due to COVID-19. American Journal of Obstetrics and Gynecology. 2020 Jul;223(1):109.e1-109.e16. doi:10.1016/j.ajog.2020.04.030.
35. Secretaria de Estado da Saúde do Maranhão – (SES/MA). Unidades Regionais de Saúde. Disponível em: https://www.saude.ma.gov.br/unidades-regionais-de-saude/. Acesso em: 01 out. 2023
36. BRASIL. Serviços e Informações do Brasil. Governo recomenda vacinação contra Covid-19 em gestantes e puérperas sem comorbidades. Disponível em: https://encurtador.com.br/cgNR8. Acesso em: 01 out. 2023.
37. Siqueira TS, de Souza EKG, Martins-Filho PR, Silva JRS, Gurgel RQ, Cuevas LE, et al. Clinical characteristics and risk factors for maternal deaths due to COVID-19 in Brazil: a nationwide population-based cohort study. Journal of Travel Medicine. 2022 May 31;29(3):taab199. doi:10.1093/jtm/taab199.
38. Porto Neto LB, Ribeiro GO, Sousa MHF, Gontijo CC, Machado DGS, Moreira MH, et al. A importância da busca ativa como estratégia no rastreio da hanseníase. Res Soc Dev. 2022;11(9):e24711931827. doi:10.33448/rsd-v11i9.31827.
39. Gordon ASA, Gomes JMS, Costa ACPJ, Serra MAAO, Neto MS, Xavier MB. Incidência de hanseníase em menores de 15 anos em Imperatriz, Maranhão. Arq Cienc Saude UNIPAR. 2017;21(1). doi:10.25110/arqsaude.v21i1.2017.6072.
40. Silva JC, Santos LFS, Santos FS, Pascoal LM, Dias ICCM, Costa ACPJ, et al. Aglomerados espaciais e espaço-temporais de tuberculose em município do Nordeste brasileiro. Saude Pesqui. 2021;14(3). doi:10.17765/2176-9206.2021v14n3e8493.
41. Lopes FC, Sousa GGS, Silva WM, Costa ACPJ, Santos FS, Pascoal LM, et al. Spatial-temporal analysis of leprosy in a priority Brazilian municipality. Rev Bras Enferm. 2021;74(3). doi:10.1590/0034-7167-2020-1101.
42. da Silva JC, de Sousa GGDS, de Oliveira RA, Santos LFS, Pascoal LM, Santos FS, et al. Spatiotemporal risk assessment and COVID-19 trend estimation in a federative unit in northeastern Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2023 Aug 3;117(8):580-590.
43. Maranhão. Governo do Maranhão. Governo entrega nova ala do Hospital Regional Materno Infantil (HRMI) em Imperatriz. Site oficial do Governo do Maranhão. Disponível em: https://encurtador.com.br/klJS4. Acesso em: 01 out. 2023.
44. World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. Geneva: World Health Organization; 2023.
45. Ochiai D, Kasuga Y, Iida M, Ikenoue S, Tanaka M. Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan. Int J Gynaecol Obstet. 2020;150(2):268–269. doi:10.1002/ijgo.13252.
46. Mirahmadizadeh A, Ghelichi-Ghojogh M, Vali M, Jokari K, Ghaem H, Hemmati A, et al. Correlation between human development index and COVID-19 indices: a global ecological study. BMC Public Health. 2022;22(1). doi:10.1186/s12889-022-13698-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Estefane Nascimento de Sousa, Pablinny da Silva Santos , Maria Luiza Vieira Araújo, Janiel Conceição da Silva, Giana Gislanne da Silva de Sousa, Marcelino Santos Neto, Ariadne Siqueira de Araújo Gordon, Janaina Miranda Bezerra
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
